Lung cancer education on social media: use patterns and content preferences from a cross-sectional study Authors: Eric K. Singhi, Susana Fortich, Victoria Yin, Mara B. Antonoff Published: 2026 ABSTRACT BackgroundSocial media is increasingly used by patients, caregivers, and clinicians to access and share cancer-related information. This study examined how individuals use social media for lung cancer education and their preferences.MethodsA cross-sectional survey was conducted on Instagram using interactive story features (polls, open-response questions) over three weeks (August to September 2025). Voluntary participation implied consent. Respondents provided demographic data and responses about social media use, content preferences, trust, and impact.ResultsAmong 182 respondents, 37% were patients, 31% caregivers, 23% clinicians, and 9% others; most were female (78%), ages 25–44 years (65%) and living in North America (75%). Social media use for lung cancer information was common, particularly on Instagram, with 66% following cancer-related accounts. Respondents preferred content from patients/survivors and practicing clinicians. Short videos/reels, patient stories, and infographics were the most favored formats, with 97% reporting diagrams/animations improved understanding; 93% reported trust in social media content and that posts improved clarity on cancer types and treatments; 70% self-reported that social media influenced a behavior and 67% reported it increased confidence in discussing care. Open response answers highlighted social media as a source of education, hope, peer connection, empowerment, and timely updates, and interest in future content on emerging therapies, conference insights, care navigation, survivorship, and personalized topics.ConclusionsRespondents frequently sought information from clinicians, with concise visual formats, and reported tangible benefits for confidence and health behaviors. Social media may offer a scalable platform for delivering real-time education on lung cancer. Highlight box Key findings • Social media is widely used for lung cancer education across patients, caregivers, and clinicians and plays a meaningful role in lung cancer education, emotional support, and decision-making among people affected by lung cancer. What is known and what is new? • Social media is an increasingly common source of cancer-related information and support. • This study reports specific content formats, tones, and clinician attributes that users prefer, as well as how online engagement shapes preparedness, empowerment, and clinical behaviors. Patients often reported that lung cancer-related information on social media increased confidence or changed a behavior. What is the implication, and what should change now? • Providers and institutions can leverage social media as a scalable platform for delivering real-time education on lung cancer and should be integrated into communication and care delivery. Introduction Social media has become a central source of health information for patients, caregivers, and clinicians, playing an increasingly important role in how individuals access, interpret, and share knowledge about lung cancer. Across platforms, users seek content that supports both educational and emotional needs, favoring information that is understandable, actionable, and relatable to their personal experiences (1-4). Patients and caregivers engage with a variety of formats, including text posts, short videos, discussion forums, and online support groups, to obtain practical guidance, learn from shared experiences, and connect with others facing similar challenges. Moderated communities and text-based forums, such as Macmillan.org.uk and Facebook support groups, are particularly valued for providing both emotional reassurance and tangible advice, often through personal narratives, coping strategies, and survivor stories (2,4). Content preferences consistently emphasize a colloquial, empathetic, and hopeful tone rather than technical or impersonal communication (1,4). Discussions frequently center on emotional wellness, survivorship, and strategies for managing treatment-related side effects, with peer-to-peer exchanges fostering a sense of empowerment and improving preparedness for clinical conversations. Yet despite these benefits, misinformation remains a significant concern; approximately 27–33% of cancer-related social media posts contain misleading or harmful information, which can generate higher engagement than accurate content (5-8). Many users, therefore, express a need for timely, trustworthy, and personalized information and seek guidance on assessing the reliability of online resources (7,9). Collectively, existing evidence shows that patients with lung cancer use social media for real-time education, emotional support, and community connection, while simultaneously facing substantial challenges related to information quality. As social media continues to shape patient understanding and influence health behaviors, clinicians are encouraged to recognize these patterns and guide patients toward reliable, high-quality resources. However, despite increasing reliance on social media for lung cancer education, little is known about how users differentiate trustworthy voices, which formats they consider most useful, or the perceived value of expert presence in these spaces. Therefore, this study aims not only to describe public preferences but also to clarify the role of clinically affiliated accounts in shaping understanding, confidence, and decision-making. The objective of this study is to characterize how social media is used for lung cancer education, identify preferred content types, formats, and communication styles and assess the value and impact of expert accounts on trust and decision-making through a self-reported survey. We present this article in accordance with the SURGE reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0265/rc). Methods Followers of a lung cancer-focused oncology account were exposed to the survey link, and participants self-selected into the study. A cross-sectional survey was conducted on Instagram via interactive story features, including polls and open-ended prompts. The survey was developed by thoracic oncology clinicians (E.K.S., M.B.A.) with expertise in patient education and digital health communication. Items were designed to assess key domains including social media use patterns, trust in health information sources, and content preferences. The survey was not formally pre-tested, pilot tested, or psychometrically validated prior to distribution. The survey remained active for 3 weeks (8/20/2025–9/3/2025), and voluntary participation was considered implied consent. Eligible respondents were adults who viewed the survey stories and chose to participate, there were no incentives. No identifying information was collected. Participants completed demographic items and questions assessing social media use, preferred content formats and tone, perceived trustworthiness of online information, and the impact of social media on their understanding and behaviors related to lung cancer. Open-ended responses were reviewed by the study team and summarized to identify recurring patterns in perceptions, preferences, and trust. Statistical analysis Descriptive statistics were used to summarize all survey responses. Categorical variables were reported as frequencies and percentages. Open-ended responses were qualitatively reviewed and summarized into recurring themes. Given the exploratory nature of this analysis, findings are presented as illustrative rather than definitive. Nonresponse error, response rates, missing data, and limitations related to Instagram-dominant recruitment visibility were considered descriptively, and stratified analyses were not performed due to the non-generalizable nature of the sample. This study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. The Institutional Review Board of the University of Texas MD Anderson Cancer Center determined that the proposed activity is not research involving human subjects as defined by Department of Health and Human Services and US Food and Drug Administration regulations; therefore, Institutional Review Board approval was not needed. Results Cohort demographics Among 182 unique respondents, 37% (n=68) were patients, 31% (n=56) were caregivers, 23% (n=42) were clinicians, and 9% (n=16) were others. Most were female (78%, 142/182) and between ages 25–44 years (65%, 118/182), with the majority residing in North America (75%, 136/182) and Europe (15%, 27/182). Educational attainment included bachelor’s degree or below (34%, 62/182), master’s/professional degree (40%, 73/182), and doctorate (22%, 40/182) (Figure 1). Patient demographics. (A) Respondent type. (B) Gender. (C) Residence. (D) Highest level of education attained. Social media use and preferences in lung cancer Social media was a common source of lung cancer information, with 80% of respondents engaging in its use, most frequently on Instagram (81%). Two-thirds (66%) actively followed cancer-related accounts, most often those run by patients/survivors (45%) and practicing clinicians (39%). Nearly all participants (95%) considered it important that the content creator be a practicing clinician who treats patients with lung cancer. Participants reported strong preferences for short videos or reels (42%), patient stories (28%), and infographics (21%). When viewing cancer-related posts, respondents were split between reading the full post (49%) or skimming for key points (49%). Format preferences favored a combination of video and text (53%), with additional preferences for video-only (24%) and text-only (10%). Almost all participants (97%) noted that diagrams or animations improved understanding (Figure 2). Social media use and format preferences for lung-cancer education. Most participants (61%) preferred frequent posting, daily or several times per week, and favored content with a blended tone incorporating scientific accuracy, patient-friendly explanations, and personal storytelling (46%). Most participants (67%) requested more content involving patient-friendly explanations of studies or trials. Qualitative responses additionally highlighted interest in topics such as: (I) emerging therapies and biomarker-driven advances; (II) conference highlights; (III) navigation of care (e.g., second opinions, first steps); (IV) survivorship and prognosis; and (V) personalized content for patient subgroups. Impact and value of social media Most respondents (91%) reported learning something valuable online from a cancer provider, and 85% had shared a cancer-related post with someone else. More than half (58%) experienced emotional support from posts created by care providers, and nearly half (48%) looked up their provider’s social media before or after a clinical visit. Additionally, 81% had either recommended a medical expert’s account to others (61%) or were open to doing so (20%). Following experts online helped 77% feel more in control of their cancer journey (Figure 3). Impact of social media on lung-cancer education and patient or caregiver cancer journey. A total of 76% participants reported that they felt somewhat to very much more prepared for treatment through social media, and 94% felt more empowered by engaging with academic experts online. Social media affected pre-appointment anxiety in both directions, with 29% reporting reduced anxiety and 21% reporting increased anxiety (Figure 3). Qualitative responses described social media as a source for: (I) education about treatments and clinical trials; (II) sharing hope and inspiration; (III) building peer connections; (IV) fostering empowerment for self-advocacy; and (V) receiving timely, accurate updates. Digital trust and decision-making Most respondents (93%) rated lung cancer information on social media as “very” or “somewhat” trustworthy. When encountering conflicting information, 80% reported trusting their doctor or oncology team the most. However, 41% had questioned or delayed a medical recommendation due to conflicting online content. Participants expressed moderate or high trust in oncologist accounts (94% combined), patient accounts (73%), and hospital or cancer center accounts (81%). Nearly half of respondents (45%) reported that social media helped them make decisions about their care or treatment options. Many indicated that posts helped them feel clearer about lung cancer types (85%) and treatment modalities (87%). A substantial proportion (70%) reported a behavior change influenced by social media, and 67% reported greater confidence discussing care with their provider due to posts from clinicians. Nearly half (49%) stated that they had brought up a social media post during a clinic visit. Among applicable respondents, 37% reported that they sought a second opinion due to a post or video online, and 45% reported bringing up clinical trials as a result of content they viewed online. Discussion This study characterizes how patients, caregivers, clinicians, and other stakeholders engage with and derive value from social media as a source of lung cancer information. Our study describes how participants perceive social media as playing a meaningful role in lung cancer education, emotional support, and decision-making. This conceptual framework is summarized in Figure 4. Consistent with prior work showing that patients seek content that is accessible, empathetic, and relevant to their experiences, our findings highlight high engagement across multiple dimensions of online interaction (1-4). Importantly, this study provides one of the most detailed descriptions to date of the specific content formats, tones, and clinician attributes that users prefer, as well as how online engagement shapes preparedness, empowerment, and clinical behaviors. Conceptual framework of social media-driven lung cancer education. A key strength of this work is the granular analysis of user preferences. Respondents overwhelmingly favored short-form video, infographics, and patient stories, and nearly all indicated that diagrams and animations enhanced understanding. Across formats, there was a clear desire for content that combines scientific accuracy with accessibility and story-telling, highlighting the need for clinicians to translate complex information into patient-friendly formats (10). The strong interest in content related to emerging therapies, biomarker-driven treatment strategies, and conference updates further underscores patients’ desire to remain closely connected to rapidly evolving scientific developments. These findings show that social media may have the potential to function as a parallel information ecosystem shaping expectations, preparedness, and decision-making in lung cancer. The impact of clinician participation on social media emerged as particularly noteworthy. Notably, 95% of participants felt it was important that content creators be practicing lung cancer specialists, underscoring a strong appetite for expert-led education in an online environment often dominated by non-experts. Many participants reported feeling emotionally supported when viewing posts from care providers, and nearly half reported that they had reviewed their provider’s social media presence before or after a clinical encounter. Some respondents stated that expert posts increased confidence in decision-making and facilitated more informed discussions with their treatment team. These findings echo the existing literature, which demonstrates that transparent, compassionate, and educational communication from clinicians can reduce uncertainty and foster patient empowerment (11-13). Importantly, our findings also highlight potential harms associated with social media engagement. A substantial proportion of respondents (41%) reported questioning or delaying a medical recommendation due to conflicting online content, and 21% reported increased anxiety related to social media. These findings underscore the potential for misinformation, disinformation, misinterpretation, and/or incomplete context to negatively influence patient perceptions and decision-making (7). They also highlight the emotional impact that health-related content may have, particularly in a population already navigating a serious diagnosis. Stigma surrounding lung cancer is a well-documented factor that may influence how individuals seek information, engage with care, and participate in online communities. Patients may experience feelings of blame or shame related to their diagnosis, which can shape both their willingness to engage with lung cancer-related content and the types of information they seek. This may contribute to selective participation in digital spaces, potentially influencing the composition of our sample as well as patterns of engagement observed in this study. Stigma may also amplify emotional responses to online content, including anxiety, and highlights the importance of creating supportive, nonjudgmental, and inclusive communication in digital environments (14,15). As such, these results emphasize the need for careful, evidence-based, and empathetic communication in digital spaces, as well as the importance of encouraging patients to discuss online information with their care teams. In addition, our data suggest that clinician-led digital engagement is not merely welcomed but may be actively sought by patients and caregivers, with expert accounts perceived as both informative and emotionally grounding. This contrasts with concerns among clinicians that patients “do not want doctors online”. and instead highlights an unmet expectation for accessible, authoritative voices to counterbalance misinformation and contextualize emerging advances. One of the most notable contributions of this study is the insight into how participants report incorporating social media into their clinical decision-making processes. Respondents reported having frequently used online information to clarify lung cancer types and treatment modalities, and many attributed real behavior changes linked to content they viewed. A substantial portion felt more confident discussing care with their provider, and nearly half had raised a social media post during a clinic visit. Importantly, 37% of respondents reported seeking a second opinion because of online content, and 45% reported discussing clinical trials. These findings highlight the increasingly bidirectional relationship between online education and in-clinic conversations and reinforce the need for clinicians to be aware of the digital influences shaping patient expectations. Our findings add to the growing body of evidence advocating for greater clinician engagement online. Participants expressed substantial interest in expert-driven content, particularly explanations of studies or clinical trials translated into patient-friendly language. Such engagement may serve as a protective factor against misinformation, helping patients differentiate credible information from misleading narratives and enabling more productive clinical conversations. Institutions and professional societies may also play a role by supporting clinicians in creating accessible educational materials that align with patient preferences. It is important to note that the findings of this study should be interpreted within the context of a highly selected and digitally engaged population. As mentioned before, the cohort was predominantly composed of younger, female, educated individuals from Western regions who were already active on Instagram and engaged with cancer-related content. As such, these results likely reflect the perceptions and behaviors of a subgroup that is more comfortable navigating digital health information and may not be representative of the broader lung cancer patient population, particularly older adults, individuals with limited digital literacy, or those without access to social media platforms. These patterns are consistent with prior literature demonstrating that social media–based health engagement is more common among younger, educated populations and that disparities in access and digital literacy may influence how individuals seek and interpret online cancer information. Additionally, previous studies have highlighted that while social media can serve as a valuable tool for education and support, its impact varies significantly depending on user demographics, platform familiarity, and baseline health literacy (16,17). Therefore, our findings should be considered exploratory and hypothesis-generating, providing insight into how a digitally engaged subgroup interacts with lung cancer–related content rather than establishing broadly generalizable conclusions. Future studies should aim to include more diverse populations across age groups, geographic regions, and levels of digital access to better understand how social media can be leveraged equitably for cancer education. Additional limitations include sampling and selection bias, which are likely present because the survey was distributed exclusively on Instagram, potentially overrepresenting individuals who are already active on social media and comfortable engaging with cancer-related content. Participants self-selected to participate and likely already engaged with lung cancer content on social media as they had already followed or were familiar with the cancer-focused Instagram account in which the survey was conducted on. As such, findings related to social media use and trust may not be generalized to all patients with lung cancer or the general public. However, this population is increasingly relevant, as social media platforms are often the first point of contact for health information. Understanding this group may inform how clinicians and institutions effectively communicate with patients who are actively seeking information online. The sample was predominantly female, younger, and from North America and Europe, which limits generalizability to older populations or those with limited digital literacy. Responses were also self-reported and subject to recall and response biases, and the cross-sectional design precludes causal conclusions. Nonetheless, the sample included a broad range of stakeholders on social media, including patients, caregivers, clinicians, and others, providing a valuable window into diverse perspectives. This study is limited by platform-restricted sampling, self-selection bias, and primarily Western demographic representation, which may underestimate preferences among older adults and non-Instagram users. In addition, the survey was not formally pre-tested, pilot tested, or validated, and measures of reliability were not assessed. Although the survey was developed by clinicians with expertise in lung cancer and patient education, it is possible that respondents interpreted questions differently than intended, which may affect the accuracy and consistency of responses. As such, findings should be interpreted as exploratory and hypothesis-generating. Future studies incorporating cognitive interviewing, pilot testing, and formal validation will be important to strengthen measurement reliability in this area. Another important limitation is the inability to assess nonresponse bias. Due to platform constraints, Instagram does not provide visibility into the total number of users who viewed the survey, precluding calculation of a response rate. As such, this study reflects only the perspectives of individuals who both encountered and chose to engage with the survey. Nonrespondents, particularly those who do not use or trust social media for health information, may hold systematically different views. This introduces potential selection and nonresponse bias, further limiting generalizability. Lastly, it was not possible to perform stratified analyses by respondent type. Although the sample included patients, caregivers, clinicians, and others, the survey design did not allow linkage of individual responses to respondent characteristics. As a result, all findings are reported in aggregate, which limits interpretation. These groups likely differ in their motivations, trust in information sources, and engagement with social media, and future studies with respondent-level data collection are needed to better characterize these differences. Future directions for research include longitudinal studies to understand how social media influences decision-making over time, as well as evaluations of specific online clinician-led interventions or educational campaigns. There is also a need to identify strategies for mitigating misinformation while enhancing trust and communication. Finally, co-developing content with patients, caregivers, and clinicians may further improve relevance and accessibility. Future work should compare platform-specific needs, evaluate engagement analytics beyond self-report, and test structured interventions—such as clinician-produced educational reels or myth-busting infographics—to determine whether expert-driven content improves preparedness, reduces misinformation exposure, or influences clinical outcomes. Integration of digital literacy counseling into supportive care pathways may also represent an actionable opportunity for thoracic oncology teams. Conclusions Among respondents engaged with a lung cancer-focused social media platform, participants reported that social media served as an important resource for education, emotional support, and decision-making. Respondents expressed a preference for content that is accurate, empathetic, and visually accessible, and reported perceived benefits from clinician participation in online spaces. At the same time, concerns about misinformation underscore the ongoing need for trustworthy, expert-led content. These findings are descriptive and should be interpreted as reflecting participant-reported experiences rather than measured effects. Overall, these findings highlight substantial opportunities for clinicians, cancer centers, and advocacy organizations to leverage social media as a powerful tool for patient education and empowerment in lung cancer. As digital platforms continue to shape how individuals understand and navigate lung cancer, intentional, evidence-based engagement from experts will be essential to supporting informed and patient-centered care. Supplementary The article’s supplementary files as Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1-0265/prf